DiaMedica Therapeutics Inc. (DMAC) Q2 2024 Earnings Call Transcript [Seeking Alpha]
DiaMedica Therapeutics Inc. (DMAC)
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
148.51K Follower s Follow Press Release 10-Q beats by $0.03 beats by $0.00 DiaMedica Therapeutics Inc. ( NASDAQ: DMAC ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Rick Pauls - President, Chief Executive Officer & Director Lorianne Masuoka - Chief Medical Officer Scott Kellen - Chief Financial Officer & Company Secretary Conference Call Participants Thomas Flaten - Lake Street Operator Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Second Quarter 2024 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations Section. Before DiaMedica proceeds with its remarks, please note that the company will be making ford looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these stat
Show less
Read more
Impact Snapshot
Event Time:
DMAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DMAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DMAC alerts
High impacting DiaMedica Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DMAC
News
- DiaMedica Therapeutics Upcoming Conference ParticipationBusiness Wire
- DiaMedica Therapeutics Inc. (NASDAQ: DMAC) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $6.00 price target on the stock.MarketBeat
- DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial ResultsBusiness Wire
- Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year? [Yahoo! Finance]Yahoo! Finance
DMAC
Earnings
- 8/7/24 - Beat
DMAC
Sec Filings
- 8/7/24 - Form 8-K
- 8/7/24 - Form 10-Q
- 7/19/24 - Form EFFECT
- DMAC's page on the SEC website